Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s

Published on April 17, 2025

Eli Lilly & Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot, bringing it one step closer to developing a needle-free alternative.

Continue reading on website
Other news

Philadelphia Fed Manufacturing Index: Sinks to 2-Year Low

April 17, 2025
The latest Philadelphia Fed manufacturing index showed a decline in activity this month. The index sank nearly 39 points to -26.4, its lowest reading in two years. The latest reading was much lower than the forecast of 2.2.

Schwab Trading Tops Estimates as Customers Cope With Volatility

April 17, 2025
Charles Schwab Corp.’s daily average trades exceeded expectations as retail investors rushed to respond to market volatility in the first three months of the year.